These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 36093587

  • 21. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies.
    Fokom-Domgue J, Combescure C, Fokom-Defo V, Tebeu PM, Vassilakos P, Kengne AP, Petignat P.
    BMJ; 2015 Jul 03; 351():h3084. PubMed ID: 26142020
    [Abstract] [Full Text] [Related]

  • 22. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.
    Torres-Ibarra L, Cuzick J, Lorincz AT, Spiegelman D, Lazcano-Ponce E, Franco EL, Moscicki AB, Mahmud SM, Wheeler CM, Rivera-Paredez B, Hernández-López R, León-Maldonado L, Salmerón J, FRIDA Study Group..
    JAMA Netw Open; 2019 Nov 01; 2(11):e1915781. PubMed ID: 31747033
    [Abstract] [Full Text] [Related]

  • 23. Screening of cervical neoplasia in HIV-infected women in India.
    Joshi S, Sankaranarayanan R, Muwonge R, Kulkarni V, Somanathan T, Divate U.
    AIDS; 2013 Feb 20; 27(4):607-15. PubMed ID: 23079814
    [Abstract] [Full Text] [Related]

  • 24. Clinical Performance of Human Papillomavirus Testing and Visual Inspection With Acetic Acid in Primary, Combination, and Sequential Cervical Cancer Screening in China.
    Wang MZ, Feng RM, Wang S, Duan XZ, Li D, Zhang X, Mu R, Qiao Y, Smith JS.
    Sex Transm Dis; 2019 Aug 20; 46(8):540-547. PubMed ID: 31295223
    [Abstract] [Full Text] [Related]

  • 25. Comprehensive Cervical Cancer Prevention in Tanzania (CONCEPT) study: Cohort profile.
    Mchome B, Swai P, Wu C, Katanga J, Kahesa C, Manongi R, Mwaiselage JD, Kjaer S, Rasch V, Linde DS.
    BMJ Open; 2020 Sep 18; 10(9):e038531. PubMed ID: 32948569
    [Abstract] [Full Text] [Related]

  • 26. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
    Rosário A, Sousa A, Marinho-Dias J, Medeiros R, Lobo C, Leça L, Coimbra N, Tavares F, Baldaque I, Martins G, Monteiro P, Henrique R, Sousa H.
    J Med Virol; 2023 Jan 18; 95(1):e28414. PubMed ID: 36541747
    [Abstract] [Full Text] [Related]

  • 27. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C, Sargent A, Kitchener HC, Peto J.
    Health Technol Assess; 2019 Jun 18; 23(28):1-44. PubMed ID: 31219027
    [Abstract] [Full Text] [Related]

  • 28. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
    Duan LF, Du H, Wang C, Huang X, Qu XF, Duan XZ, Liu Y, Shi B, Zhang W, Wei LH, Belinson L, Wu RF.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Oct 25; 55(10):708-715. PubMed ID: 33120484
    [Abstract] [Full Text] [Related]

  • 29. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
    Pan QJ, Hu SY, Guo HQ, Zhang WH, Zhang X, Chen W, Cao J, Jiang Y, Zhao FH, Qiao YL.
    Gynecol Oncol; 2014 May 25; 133(2):172-9. PubMed ID: 24631450
    [Abstract] [Full Text] [Related]

  • 30. [A study of cervical cancer screening algorithms].
    Zhao FH, Zhang WH, Pan QJ, Zhang X, Chen W, Liu B, Ma JF, Hu SY, Qiao YL.
    Zhonghua Zhong Liu Za Zhi; 2010 Jun 25; 32(6):420-4. PubMed ID: 20819481
    [Abstract] [Full Text] [Related]

  • 31. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, Schünemann H, Paraskevaidis E, Arbyn M.
    Cochrane Database Syst Rev; 2017 Aug 10; 8(8):CD008587. PubMed ID: 28796882
    [Abstract] [Full Text] [Related]

  • 32. Assessment of high-risk human papillomavirus infections and associated cervical dysplasia in HIV-positive pregnant women in Germany: a prospective cross-sectional two-centre study.
    Metz CK, Skof AS, Sehouli J, Siedentopf JP, Gebert P, Weiss F, Alba Alejandre I, Heinrich-Rohr M, Weizsaecker K, Henrich W, Kaufmann AM, Rohr I.
    Arch Gynecol Obstet; 2023 Jul 10; 308(1):207-218. PubMed ID: 36576558
    [Abstract] [Full Text] [Related]

  • 33. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ, Dai Y, Dang L, Kong LH, Zhang Y, Feng RM, Qiao YL, Lang JH.
    Zhonghua Zhong Liu Za Zhi; 2018 Oct 23; 40(10):764-771. PubMed ID: 30392341
    [Abstract] [Full Text] [Related]

  • 34. A cross-sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese women.
    Wu Q, Zhao X, Fu Y, Wang X, Zhang X, Tian X, Cheng B, Lu B, Yu X, Lan S, Lu W, Ma D, Cheng X, Xie X.
    Cancer Med; 2017 May 23; 6(5):1091-1101. PubMed ID: 28378404
    [Abstract] [Full Text] [Related]

  • 35. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women.
    La Ruche G, You B, Mensah-Ado I, Bergeron C, Montcho C, Ramon R, Touré-Coulibaly K, Welffens-Ekra C, Dabis F, Orth G.
    Int J Cancer; 1998 May 18; 76(4):480-6. PubMed ID: 9590121
    [Abstract] [Full Text] [Related]

  • 36. The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening.
    Song F, Du H, Wang C, Huang X, Qu X, Wei L, Belinson JL, Wu R, CHIMUST team.
    J Med Screen; 2021 Sep 18; 28(3):318-324. PubMed ID: 32869705
    [Abstract] [Full Text] [Related]

  • 37. High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.
    Reddy D, Njala J, Stocker P, Schooley A, Flores M, Tseng CH, Pfaff C, Jansen P, Mitsuyasu RT, Hoffman RM.
    Int J STD AIDS; 2015 May 18; 26(6):379-87. PubMed ID: 24928579
    [Abstract] [Full Text] [Related]

  • 38. The Influence of Human Papillomavirus Genotypes on Visual Screening and Diagnosis of Cervical Precancer and Cancer.
    Jeronimo J, Bansil P, Valdez M, Kang LN, Zhao FH, Qiao YL, Chen W, Zhang X, Paul P, Bai P, Peck R, Li J, Chen F, Stoler MH, Castle PE.
    J Low Genit Tract Dis; 2015 Jul 18; 19(3):220-3. PubMed ID: 25279978
    [Abstract] [Full Text] [Related]

  • 39. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
    Di Salvo I, Mnzava D, Nicoletti GJ, Senkoro E, Ndege RC, Huang DJ, Makunja NT, Kassiga GI, Kaufmann AM, Weisser M, Kind AB.
    BMC Health Serv Res; 2023 Mar 10; 23(1):234. PubMed ID: 36894985
    [Abstract] [Full Text] [Related]

  • 40. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.
    Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, Alfaro M, Hutchinson M, Morales J, Greenberg MD, Lorincz AT.
    JAMA; 2000 Jan 05; 283(1):87-93. PubMed ID: 10632285
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.